Latest News
September 28, 2016
Quanterix And Immunarray Teaming Up To Address Neurodegenerative Disease
Quanterix gains access to ImmunArray brain injury biomarker portfolio and ImmunArray gains access to Quanterix state of the art digital biomarker technology.
July 18, 2016
Immunarray Expanding Research And Clinical Momentum On TBI Front
Molecular diagnostic company’s research into blood-based diagnosis of traumatic brain injury presented at national conferences.
July 12, 2016
Private Investment Group Leads $10 Million B Funding Round In Immunarray
Exigent announces investment in molecular diagnostic company during visit by Virginia Governor Terry McAuliffe to Jerusalem.
January 23, 2014
$300,000 GE NFL Head Health Challenge Grant Will Fund Research Based On Johns Hopkins-Licensed Patents Connecting Protein Markers In Blood And Acute Brain Injury
ImmunArray, the Richmond, Va. and Rehovot, Israel-based developer of a breakthrough chip-based technology with the capacity to detect the presence of…
Publications
Nothing found.